573 related articles for article (PubMed ID: 31687922)
1. Percutaneous Irreversible Electroporation in Locally Advanced and Recurrent Pancreatic Cancer (PANFIRE-2): A Multicenter, Prospective, Single-Arm, Phase II Study.
Ruarus AH; Vroomen LGPH; Geboers B; van Veldhuisen E; Puijk RS; Nieuwenhuizen S; Besselink MG; Zonderhuis BM; Kazemier G; de Gruijl TD; van Lienden KP; de Vries JJJ; Scheffer HJ; Meijerink MR
Radiology; 2020 Jan; 294(1):212-220. PubMed ID: 31687922
[TBL] [Abstract][Full Text] [Related]
2. Ablation of Locally Advanced Pancreatic Cancer with Percutaneous Irreversible Electroporation: Results of the Phase I/II PANFIRE Study.
Scheffer HJ; Vroomen LG; de Jong MC; Melenhorst MC; Zonderhuis BM; Daams F; Vogel JA; Besselink MG; van Kuijk C; Witvliet J; de van der Schueren MA; de Gruijl TD; Stam AG; van den Tol PM; van Delft F; Kazemier G; Meijerink MR
Radiology; 2017 Feb; 282(2):585-597. PubMed ID: 27604035
[TBL] [Abstract][Full Text] [Related]
3. Value of CT-Guided Percutaneous Irreversible Electroporation Added to FOLFIRINOX Chemotherapy in Locally Advanced Pancreatic Cancer: A Post Hoc Comparison.
van Veldhuisen E; Vroomen LG; Ruarus AH; Derksen TC; Busch OR; de Jong MC; Kazemier G; Puijk RS; Sorgedrager NS; Vogel JA; Scheffer HJ; van Lienden KP; Wilmink JW; Besselink MG; Meijerink MR
J Vasc Interv Radiol; 2020 Oct; 31(10):1600-1608. PubMed ID: 32861569
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous CT-guided irreversible electroporation followed by chemotherapy as a novel neoadjuvant protocol in locally advanced pancreatic cancer: Our preliminary experience.
Belfiore MP; Ronza FM; Romano F; Ianniello GP; De Lucia G; Gallo C; Marsicano C; Di Gennaro TL; Belfiore G
Int J Surg; 2015 Sep; 21 Suppl 1():S34-9. PubMed ID: 26118600
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous Image-Guided Irreversible Electroporation for the Treatment of Unresectable, Locally Advanced Pancreatic Adenocarcinoma.
Narayanan G; Hosein PJ; Beulaygue IC; Froud T; Scheffer HJ; Venkat SR; Echenique AM; Hevert EC; Livingstone AS; Rocha-Lima CM; Merchan JR; Levi JU; Yrizarry JM; Lencioni R
J Vasc Interv Radiol; 2017 Mar; 28(3):342-348. PubMed ID: 27993507
[TBL] [Abstract][Full Text] [Related]
6. Irreversible Electroporation (IRE) Combined With Chemotherapy Increases Survival in Locally Advanced Pancreatic Cancer (LAPC).
Oikonomou D; Karamouzis MV; Moris D; Dimitrokallis N; Papamichael D; Kountourakis P; Astras G; Davakis S; Papalampros A; Schizas D; Petrou AS; Felekouras E
Am J Clin Oncol; 2021 Jul; 44(7):325-330. PubMed ID: 33979098
[TBL] [Abstract][Full Text] [Related]
7. Ultrasound-guided Percutaneous Irreversible Electroporation for Treatment of Locally Recurrent Pancreatic Cancer After Surgical Resection.
Månsson C; Nilsson A; Nygren P; Karlson BM
Anticancer Res; 2020 May; 40(5):2771-2775. PubMed ID: 32366423
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III/IV) pancreatic cancer: a promising treatment.
Lin M; Liang S; Wang X; Liang Y; Zhang M; Chen J; Niu L; Xu K
J Cancer Res Clin Oncol; 2017 Dec; 143(12):2607-2618. PubMed ID: 28871458
[TBL] [Abstract][Full Text] [Related]
9. Treatment of locally advanced pancreatic cancer with irreversible electroporation - a Danish single center study of safety and feasibility.
Flak RV; Stender MT; Jensen TM; Andersen KL; Henriksen SD; Mortensen PB; Sall M; Thorlacius-Ussing O
Scand J Gastroenterol; 2019 Feb; 54(2):252-258. PubMed ID: 30907286
[TBL] [Abstract][Full Text] [Related]
10. Comparison of combination therapies in the management of locally advanced pancreatic cancer: Induction chemotherapy followed by irreversible electroporation vs radiofrequency ablation.
He C; Wang J; Zhang Y; Cai Z; Lin X; Li S
Cancer Med; 2020 Jul; 9(13):4699-4710. PubMed ID: 32410380
[TBL] [Abstract][Full Text] [Related]
11. MRI-guided stereotactic ablative body radiotherapy versus CT-guided percutaneous irreversible electroporation for locally advanced pancreatic cancer (CROSSFIRE): a single-centre, open-label, randomised phase 2 trial.
Timmer FEF; Geboers B; Ruarus AH; Vroomen LGPH; Schouten EAC; van der Lei S; Vos DJW; Dijkstra M; Schulz HH; Bakker J; van den Bemd BAT; van den Tol PM; Puijk RS; Lissenberg-Witte BI; de Gruijl TD; de Vries JJJ; Lagerwaard FJ; Scheffer HJ; Bruynzeel AME; Meijerink MR
Lancet Gastroenterol Hepatol; 2024 May; 9(5):448-459. PubMed ID: 38513683
[TBL] [Abstract][Full Text] [Related]
12. A prospective, multi-institution assessment of irreversible electroporation for treatment of locally advanced pancreatic adenocarcinoma: initial outcomes from the AHPBA pancreatic registry.
Holland MM; Bhutiani N; Kruse EJ; Weiss MJ; Christein JD; White RR; Huang KW; Martin RCG
HPB (Oxford); 2019 Aug; 21(8):1024-1031. PubMed ID: 30737097
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factor analysis of irreversible electroporation for locally advanced pancreatic cancer - A multi-institutional clinical study in Asia.
Yang PC; Huang KW; Pua U; Kim MD; Li SP; Li XY; Liang PC
Eur J Surg Oncol; 2020 May; 46(5):811-817. PubMed ID: 31839436
[TBL] [Abstract][Full Text] [Related]
14. Treatment of 200 locally advanced (stage III) pancreatic adenocarcinoma patients with irreversible electroporation: safety and efficacy.
Martin RC; Kwon D; Chalikonda S; Sellers M; Kotz E; Scoggins C; McMasters KM; Watkins K
Ann Surg; 2015 Sep; 262(3):486-94; discussion 492-4. PubMed ID: 26258317
[TBL] [Abstract][Full Text] [Related]
15. Single-Institution Experience with Irreversible Electroporation for T4 Pancreatic Cancer: First 50 Patients.
Kluger MD; Epelboym I; Schrope BA; Mahendraraj K; Hecht EM; Susman J; Weintraub JL; Chabot JA
Ann Surg Oncol; 2016 May; 23(5):1736-43. PubMed ID: 26714959
[TBL] [Abstract][Full Text] [Related]
16. Optimizing Patient Selection for Irreversible Electroporation of Locally Advanced Pancreatic Cancer: Analyses of Survival.
Woeste MR; Wilson KD; Kruse EJ; Weiss MJ; Christein JD; White RR; Martin RCG
Front Oncol; 2021; 11():817220. PubMed ID: 35096621
[TBL] [Abstract][Full Text] [Related]
17. Initial experience of irreversible electroporation for locally advanced pancreatic cancer in a Korean population.
Kwon JH; Chung MJ; Park JY; Lee HS; Hwang HK; Kang CM; Lee WJ; Park MS; Kim N; Bang S; Kim MD
Acta Radiol; 2021 Feb; 62(2):164-171. PubMed ID: 32295390
[TBL] [Abstract][Full Text] [Related]
18. Irreversible Electroporation for Nonthermal Tumor Ablation in Patients with Locally Advanced Pancreatic Cancer: Initial Clinical Experience in Japan.
Sugimoto K; Moriyasu F; Tsuchiya T; Nagakawa Y; Hosokawa Y; Saito K; Tsuchida A; Itoi T
Intern Med; 2018 Nov; 57(22):3225-3231. PubMed ID: 29984761
[TBL] [Abstract][Full Text] [Related]
19. [Combining intraoperative ultrasound-guided irreversible electroporation with chemotherapy for treating locally advanced pancreatic cancer: a clinical report of 64 cases].
Li SP; He CB; Wang J; Mao YZ; Lao XM; Cui BK; Lin XJ
Zhonghua Wai Ke Za Zhi; 2020 Oct; 58(10):787-792. PubMed ID: 32993267
[No Abstract] [Full Text] [Related]
20. Irreversible electroporation versus radiotherapy after induction chemotherapy on survival in patients with locally advanced pancreatic cancer: a propensity score analysis.
He C; Wang J; Sun S; Zhang Y; Lin X; Lao X; Cui B; Li S
BMC Cancer; 2019 Apr; 19(1):394. PubMed ID: 31029111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
